HCC and Molecular Targeting Therapies: Back to the Future

Hepatocellular carcinoma (HCC) is one of the leading causes of death from cancer in the world. Recently, the effectiveness of new antiviral therapies and the HBV vaccine have reduced HCC’s incidence, while non-alcoholic steato-hepatitis is an emerging risk factor. This review focuses on antiangiogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinaldi, Luca, Vetrano, Erica, Rinaldi, Barbara, Galiero, Raffaele, Caturano, Alfredo, Salvatore, Teresa, Sasso, Ferdinando Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533575/
https://www.ncbi.nlm.nih.gov/pubmed/34680462
http://dx.doi.org/10.3390/biomedicines9101345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533575/
https://www.ncbi.nlm.nih.gov/pubmed/34680462
http://dx.doi.org/10.3390/biomedicines9101345

Ejemplares similares